SCHEMBL2460153

SCHEMBL2460153

c1cc(-c2ccc3ncsc3c2)[nH]n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK2 O43353 1/20 0.55
RIPK3 Q9Y572 1/20 0.55
RIPK1 Q13546 1/20 0.55
PFKFB3 Q16875 1/20 0.53
DYRK1A Q13627 1/20 0.50
NOTUM Q6P988 5/20 0.47
CYP4F2 P78329 1/20 0.46
CYP4A11 Q02928 1/20 0.46
POLB P06746 1/20 0.43
PTPN11 Q06124 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP19A1 P11511 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HPGDS O60760 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
JAK2 O60674 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2462260 0.87 RIPK2 (0.61) RIPK2RIPK3RIPK1PFKFB3NOTUM
SCHEMBL15918180 0.79 CYP4F2 (0.48) RIPK2RIPK3PFKFB3CYP4F2CYP4A11
SCHEMBL31214345 0.78 DYRK1A (0.72) RIPK1PFKFB3DYRK1ANPC1RAB9A
SCHEMBL2457852 0.74 PFKFB3 (0.55) RIPK1PFKFB3DYRK1ANPC1RAB9A
SCHEMBL2463712 0.74 NOTUM (0.47) RIPK2RIPK3NOTUMPOLBPTPN11
SCHEMBL2458769 0.73 RIPK1 (0.50) RIPK1DYRK1APOLBCYP1A2CYP3A4
SCHEMBL2464313 0.72 NPC1 (0.50) DYRK1ANOTUMPOLBPTPN11HPGDS
SCHEMBL2457178 0.71 DYRK1A (0.54) RIPK1PFKFB3DYRK1ANPC1RAB9A
SCHEMBL2461409 0.71 DYRK1A (0.50) RIPK1PFKFB3DYRK1ACYP1A2CYP3A4
SCHEMBL16437088 0.71 DYRK1A (0.50) RIPK1DYRK1ANPC1RAB9AAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET RIPK2 3574/4885RIPK3 3776/4885RIPK1 3658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.